SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,670.00    20.00 (0.35%)
Bid:
5,660.00
Ask:
5,680.00
Spread: 20.00 (0.353%)
Market Cap: £3.04b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Third Quarter Trading Statement

17 Jan 2020 07:00

RNS Number : 0940A
Cranswick PLC
17 January 2020
 

 

17 January 2020

 

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

 

Third quarter trading statement

 

Cranswick plc ("Cranswick", the "Company", or the Group") today releases an unscheduled trading update.

 

Current trading

The Group's Adjusted Profit Before Tax (under IFRS16, pre-exceptionals) for the year ending 31 March 2020 is now expected to be higher than current market forecasts.

 

The interim results announcement dated 26 November 2019 stated the Group had delivered a robust performance, in a competitive UK market. That performance, and market backdrop, in the UK continued over the important Christmas trading period. Revenue growth was positive across each of the Group's four product categories.

 

Export sales have continued to be exceptionally strong and the outlook remains positive. As stated in our interim results announcement, African Swine Fever ("ASF") has created opportunities for Far Eastern exports assuming the UK remains ASF free. The UK industry remains on high alert with intensive biosecurity protocols in place.

 

Investment

The commissioning of the world class £75m primary poultry processing facility in Eye, Suffolk continues to plan, with the "ramp up" phase now underway.

 

The Group has accelerated investment in its pig farming and rearing operations during the period through the acquisition of Packington Pork Limited. The transaction materially increases Cranswick's self-sufficiency in UK pigs processed, securing direct control over a significant part of the Group's supply chain for premium pigs and further reinforcing its commitment to developing a sustainable and traceable farm to fork operation. Ongoing investment in the Group's farming operations is a key component of Cranswick's 'Second Nature' sustainability strategy which aims to create a unique, industry leading sustainability standard for the food industry.

 

Financial position

As expected, net debt increased during the period reflecting the usual seasonal uplift in working capital, the Group's substantial ongoing capital investment programme and, as previously reported, the acquisition of Packington Pork Limited in December 2019.

 

The Group's borrowings continue to be managed conservatively with committed, unsecured facilities of £200 million providing considerable headroom to support the Group's growth strategy.

 

Outlook

The Board is confident that continued focus on the strengths of the Company, which include its long-standing customer relationships, breadth and quality of products, robust financial position and industry leading asset infrastructure, will support the further successful development of the Group over the longer term.

 

Preliminary results

The Company will announce its preliminary results for the year ending 31 March 2020 on 19 May 2020.

 

 

 

 

Enquiries:

 

Cranswick plc

01482 275 000

Mark Bottomley, Finance Director

Powerscourt

020 7250 1446

Nick Dibden / Lisa Kavanagh

cranswick@powerscourt-group.com

 

Notes:

1. Cranswick is a leading and innovative supplier of premium, fresh and added value food products. The business employs over 10,000 people and operates from fifteen well invested, highly efficient production facilities in the UK. The Group produces a range of high quality, predominantly fresh food, including fresh pork, poultry, convenience and gourmet products. Through the Group's four primary processing and eleven added value processing facilities the business develops innovative, great tasting food products to the highest standards of food safety and traceability. The Group supplies the major grocery multiples as well as the growing premium and discounter retail channels. Cranswick also has a strong presence in the 'food-to-go' sector and a rapidly growing export business. Results for the year to 31 March 2019 showed revenue of £1,437m and profit before tax of £86.5m.

2. Cranswick is committed to ensuring that its business activities are sustainable from farm to fork. Our ambitious sustainability strategy 'Second Nature' has been developed to deliver our vision to become the world's most sustainable meat business. Find out more at thisissecondnature.co.uk

3. This announcement is based on information sourced from unaudited management accounts.

4. This announcement contains certain forward-looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFIALLIRLII
Date   Source Headline
18th May 20217:00 amRNSChange of Chairmanship
18th May 20217:00 amRNSPreliminary Results
4th May 20213:56 pmRNSTotal Voting Rights
1st Apr 20213:32 pmRNSBlock listing Interim Review
1st Apr 20213:31 pmRNSBlock listing Interim Review
1st Apr 20213:29 pmRNSTotal Voting Rights
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:47 amRNSDirector/PDMR Shareholding
23rd Mar 20216:03 pmRNSHolding(s) in Company
23rd Mar 20219:07 amRNSDirector/PDMR Shareholding
23rd Mar 20219:06 amRNSDirector/PDMR Shareholding
16th Mar 20211:29 pmRNSDirector/PDMR Shareholding
16th Mar 20218:30 amRNSNon-Executive Director Appointment
2nd Mar 20217:30 amRNSDirector/PDMR Shareholding
15th Feb 20212:59 pmRNSDirector/PDMR Shareholding
4th Feb 20217:00 amRNSThird Quarter Trading Statement
1st Feb 202110:29 amRNSTotal Voting Rights
28th Jan 20213:01 pmRNSAdditional Listing
28th Jan 20217:44 amRNSAdditional Listing
25th Jan 202112:31 pmRNSDirectorship
13th Jan 20218:38 amRNSHolding(s) in Company
4th Jan 20212:19 pmRNSTotal Voting Rights
24th Dec 20207:51 amRNSHolding(s) in Company
24th Dec 20207:49 amRNSDividend Announcement
17th Dec 20207:00 amRNSWithdrawal from Acquisition Process
16th Dec 202011:22 amRNSResponse to Press Speculation
11th Dec 20208:39 amRNSHolding(s) in Company
1st Dec 20208:26 amRNSTotal Voting Rights
24th Nov 20203:45 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSInterim Results
18th Nov 20204:37 pmRNSHolding(s) in Company
3rd Nov 20205:15 pmRNSTotal Voting Rights
27th Oct 20202:55 pmRNSHolding(s) in Company
27th Oct 20202:51 pmRNSHolding(s) in Company
26th Oct 202011:51 amRNSHolding(s) in Company
1st Oct 20201:54 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20201:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20201:49 pmRNSTotal Voting Rights
25th Sep 20202:34 pmRNSHolding(s) in Company
2nd Sep 20202:01 pmRNSAdditional Listing
1st Sep 202011:45 amRNSDirector/PDMR Shareholding
1st Sep 202011:18 amRNSTotal Voting Rights
17th Aug 20202:57 pmRNSPoll Result for 2020 Annual General Meeting
17th Aug 20207:00 amRNSFirst quarter trading statement
11th Aug 20207:00 amRNSAnnual General Meeting update
3rd Aug 20202:30 pmRNSTotal Voting Rights
31st Jul 202012:26 pmRNSDirector/PDMR Shareholding
31st Jul 202012:26 pmRNSDirector/PDMR Shareholding
31st Jul 202012:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.